Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Attention deficit/hyperactivity disorder
ADR ID BADD_A00383
ADR Hierarchy
19      Psychiatric disorders
19.21      Cognitive and attention disorders and disturbances
19.21.04      Attention deficit and disruptive behaviour disorders
19.21.04.001      Attention deficit/hyperactivity disorder
Description A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V) [MeSH]
MedDRA Code 10003736
MeSH ID D001289
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
ADD | ADDH | Attention deficit disorder | Attention deficit disorder of childhood | Attention deficit disorder of childhood with hyperactivity | Attention deficit disorder of childhood without mention of hyperactivity | Attention deficit-hyperactivity disorder | Attention deficit/hyperactivity disorder | Attention deficit/hyperactivity disorder NOS | Hyperactive child syndrome | Hyperkinesis of childhood with developmental delay | Hyperkinetic conduct disorder of childhood | Hyperkinetic syndrome | Hyperkinetic syndrome of childhood | Other specified manifestations of hyperkinetic syndrome of childhood | Overactive child | Syndrome hyperkinetic | Unspecified hyperkinetic syndrome of childhood | Hyperactivity syndrome aggravated | ADHD | ADHD, combined type | ADHD, predominantly hyperactive-impulsive type | ADHD, predominantly inattentive type | Attention Deficit Disorder with Hyperactivity | Attention Deficit Disorders with Hyperactivity | Attention Deficit Hyperactivity Disorders | Attention Deficit-Hyperactivity Disorder | Attention Deficit-Hyperactivity Disorders | Deficit-Hyperactivity Disorder, Attention | Deficit-Hyperactivity Disorders, Attention | Disorder, Attention Deficit-Hyperactivity | Disorders, Attention Deficit-Hyperactivity | Hyperkinetic Syndrome | Syndromes, Hyperkinetic | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder | Attention Deficit Disorders | Deficit Disorder, Attention | Deficit Disorders, Attention | Disorder, Attention Deficit | Disorders, Attention Deficit | Brain Dysfunction, Minimal | Dysfunction, Minimal Brain | Minimal Brain Dysfunction
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00165Aripiprazole0.001526%
BADD_D00180Atomoxetine0.003472%
BADD_D00356Carbamazepine0.002105%
BADD_D00475Citalopram0.000083%
BADD_D00501Clonazepam--
BADD_D00502Clonidine0.000206%
BADD_D00680Dimethyl fumarate--
BADD_D00749Efavirenz0.050464%
BADD_D00809Escitalopram0.000142%
BADD_D00812Eslicarbazepine acetate--
BADD_D00879Fentanyl--
BADD_D00898Finasteride0.003421%
BADD_D00932Fluoxetine0.001271%
BADD_D00981Gabapentin0.000076%
BADD_D01003Ganciclovir--
BADD_D01213Isotretinoin0.002526%
BADD_D01243Lamotrigine0.003995%
BADD_D01265Levetiracetam0.001333%
BADD_D01275Levofloxacin0.000260%
BADD_D01281Levonorgestrel--
BADD_D01366Medroxyprogesterone acetate--
BADD_D01431Methylphenidate0.002112%
BADD_D01496Montelukast0.000208%
BADD_D01547Nefazodone hydrochloride--
BADD_D01572Nitisinone0.064083%
BADD_D01617Ondansetron0.000949%
BADD_D01637Oxcarbazepine0.001247%
BADD_D01679Paroxetine0.002057%
BADD_D01765Phenytoin0.000819%
BADD_D01834Prednisone0.000040%
The 1th Page    1 2    Next   Last    Total 2 Pages